95 related articles for article (PubMed ID: 12684669)
1. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
[TBL] [Abstract][Full Text] [Related]
2. ATM-mediated stabilization of hMutL DNA mismatch repair proteins augments p53 activation during DNA damage.
Luo Y; Lin FT; Lin WC
Mol Cell Biol; 2004 Jul; 24(14):6430-44. PubMed ID: 15226443
[TBL] [Abstract][Full Text] [Related]
3. Expression of Mismatch Repair Proteins in Early and Advanced Gastric Cancer in Poland.
Karpińska-Kaczmarczyk K; Lewandowska M; Ławniczak M; Białek A; Urasińska E
Med Sci Monit; 2016 Aug; 22():2886-92. PubMed ID: 27527654
[TBL] [Abstract][Full Text] [Related]
4. Pms2 suppresses large expansions of the (GAA·TTC)n sequence in neuronal tissues.
Bourn RL; De Biase I; Pinto RM; Sandi C; Al-Mahdawi S; Pook MA; Bidichandani SI
PLoS One; 2012; 7(10):e47085. PubMed ID: 23071719
[TBL] [Abstract][Full Text] [Related]
5. Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity.
Wilentz RE; Goggins M; Redston M; Marcus VA; Adsay NV; Sohn TA; Kadkol SS; Yeo CJ; Choti M; Zahurak M; Johnson K; Tascilar M; Offerhaus GJ; Hruban RH; Kern SE
Am J Pathol; 2000 May; 156(5):1641-51. PubMed ID: 10793075
[TBL] [Abstract][Full Text] [Related]
6. ATR functions as a gene dosage-dependent tumor suppressor on a mismatch repair-deficient background.
Fang Y; Tsao CC; Goodman BK; Furumai R; Tirado CA; Abraham RT; Wang XF
EMBO J; 2004 Aug; 23(15):3164-74. PubMed ID: 15282542
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological Implications of Mismatch Repair Status in Endometrioid Endometrial Cancer in Duhok City.
Ali GS; Yaqo RT; Abdullah MA
Cureus; 2024 Mar; 16(3):e56861. PubMed ID: 38659537
[TBL] [Abstract][Full Text] [Related]
8. The expression of mismatched repair genes and their correlation with clinicopathological parameters and response to neo-adjuvant chemotherapy in breast cancer.
Chintamani ; Jha BP; Bhandari V; Bansal A; Saxena S; Bhatnagar D
Int Semin Surg Oncol; 2007 Feb; 4():5. PubMed ID: 17394628
[TBL] [Abstract][Full Text] [Related]
9. MRE11A: a novel negative regulator of human DNA mismatch repair.
Du D; Yang Y; Zhang Y; Wang G; Chen L; Guan X; Rasmussen LJ; Liu D
Cell Mol Biol Lett; 2024 Mar; 29(1):37. PubMed ID: 38486171
[TBL] [Abstract][Full Text] [Related]
10. Caenorhabditis elegans DNA mismatch repair gene msh-2 is required for microsatellite stability and maintenance of genome integrity.
Degtyareva NP; Greenwell P; Hofmann ER; Hengartner MO; Zhang L; Culotti JG; Petes TD
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2158-63. PubMed ID: 11830642
[TBL] [Abstract][Full Text] [Related]
11. Increased incidence of endometrioid tumors caused by aberrations in E-cadherin promoter of mismatch repair-deficient mice.
Kovtun IV; Harris KJ; Jatoi A; Jevremovic D
Carcinogenesis; 2011 Jul; 32(7):1085-92. PubMed ID: 21551128
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry.
Rosty C; Walsh MD; Lindor NM; Thibodeau SN; Mundt E; Gallinger S; Aronson M; Pollett A; Baron JA; Pearson S; Clendenning M; Walters RJ; Nagler BN; Crawford WJ; Young JP; Winship I; Win AK; Hopper JL; Jenkins MA; Buchanan DD
Fam Cancer; 2014 Dec; 13(4):573-82. PubMed ID: 25117503
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of mismatch repair proteins (MSH2, MSH6, MLH1, and PMS2) in prostate cancer: correlation with grade groups (WHO 2016) and ERG and PTEN status.
Albero-González R; Hernández-Llodrà S; Juanpere N; Lorenzo M; Lloret A; Segalés L; Duran X; Fumadó L; Cecchini L; Lloreta-Trull J
Virchows Arch; 2019 Aug; 475(2):223-231. PubMed ID: 31209634
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.
Latham A; Srinivasan P; Kemel Y; Shia J; Bandlamudi C; Mandelker D; Middha S; Hechtman J; Zehir A; Dubard-Gault M; Tran C; Stewart C; Sheehan M; Penson A; DeLair D; Yaeger R; Vijai J; Mukherjee S; Galle J; Dickson MA; Janjigian Y; O'Reilly EM; Segal N; Saltz LB; Reidy-Lagunes D; Varghese AM; Bajorin D; Carlo MI; Cadoo K; Walsh MF; Weiser M; Aguilar JG; Klimstra DS; Diaz LA; Baselga J; Zhang L; Ladanyi M; Hyman DM; Solit DB; Robson ME; Taylor BS; Offit K; Berger MF; Stadler ZK
J Clin Oncol; 2019 Feb; 37(4):286-295. PubMed ID: 30376427
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review.
Maekawa S; Takata R; Obara W
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339274
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and molecular analysis of microsatellite instability in prostate cancer: a multi-institutional study in China.
Zhang H; Yang X; Xie J; Cheng X; Chen J; Shen M; Ding W; Wang S; Zhang Z; Wang C; Zhao M
Front Oncol; 2023; 13():1277233. PubMed ID: 37901334
[TBL] [Abstract][Full Text] [Related]
17. Expression differences between proteins responsible for DNA damage repair according to the Gleason grade as a new heterogeneity marker in prostate cancer.
Jaworski D; Gzil A; Antosik P; Zarębska I; Dominiak J; Neska-Długosz I; Kasperska A; Grzanka D; Szylberg Ł
Arch Med Sci; 2023; 19(2):499-506. PubMed ID: 37034507
[TBL] [Abstract][Full Text] [Related]
18. Rare germline mutations in African American men diagnosed with early-onset prostate cancer.
Beebe-Dimmer JL; Zuhlke KA; Johnson AM; Liesman D; Cooney KA
Prostate; 2018 Apr; 78(5):321-326. PubMed ID: 29356034
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer.
Wadosky KM; Koochekpour S
Oncotarget; 2016 Sep; 7(39):64447-64470. PubMed ID: 27487144
[TBL] [Abstract][Full Text] [Related]
20. A cohort analysis of men with a family history of BRCA1/2 and Lynch mutations for prostate cancer.
Kerr L; Rewhorn MJ; Longmuir M; Fraser S; Walsh S; Andrew N; Leung HY
BMC Cancer; 2016 Jul; 16():529. PubMed ID: 27456091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
